Skip to main content
. 2018 Apr 10;9(27):18821–18831. doi: 10.18632/oncotarget.24568

Figure 1. Inhibitory effects of DSF on ADAM10 in vitro.

Figure 1

(A) The in vitro ADAM10 enzyme assay system was validated using the known inhibitor MMS as a positive control. (B) The effects of 636 compounds in the FDA-Approved Drug Screen-well Library were tested in vitro. (C) The chemical structures of DSF and its analogues and metabolites, retrieved from the database ChemSpider. In vitro effects of (D) DSF, TR and TMTM at 0.5, 1, and 10 μM, and (E) DDC, DETC-MeSO and DDTC-MeSO at 1 and 10 μM.